Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence

2016 
Background Clinicians are required to assimilate, critically evaluate, and extrapolate information to support appropriate use of biosimilars across indications.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    118
    References
    34
    Citations
    NaN
    KQI
    []